Capstone Investment Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.32M Buy
46,600
+18,500
+66% +$1.46M 0.01% 513
2025
Q4
$2.3M Sell
28,100
-22,400
-44% -$1.75M ﹤0.01% 578
2025
Q3
$3.79M Buy
50,500
+17,700
+54% +$1.32M 0.01% 560
2025
Q2
$2.43M Sell
32,800
-7,600
-19% -$529K 0.01% 584
2025
Q1
$3.26M Buy
40,400
+9,900
+32% +$851K 0.01% 557
2024
Q4
$2.38M Buy
30,500
+21,500
+239% +$1.83M 0.01% 791
2024
Q3
$845K Buy
9,000
+3,400
+61% +$285K ﹤0.01% 1018
2024
Q2
$436K Buy
+5,600
New +$457K ﹤0.01% 1381

Other funds holding GEHC

Capstone Investment Advisors's GEHC Position: Q1 2026 in Review

Capstone Investment Advisors reduced its GE HealthCare (GEHC) stake by 56% in Q1 2026, selling an estimated $489K and leaving 4,781 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #1313.

Capstone Investment Advisors first reported a position in GEHC in Q3 2023 and has held it in 11 quarters since. The position peaked at $48.3M in Q1 2024. 1,268 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Capstone Investment Advisors held 4,781 shares of GE HealthCare worth $340K as of Q1 2026.
  • Capstone Investment Advisors sold 6,201 GE HealthCare shares in Q1 2026, an estimated $489K.
  • GE HealthCare made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1313 holding.
  • Capstone Investment Advisors first reported a position in GE HealthCare in Q3 2023 and has held it in 11 quarters since.
  • Capstone Investment Advisors's GE HealthCare position peaked at $48.3M in Q1 2024.
  • 1,268 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.